Jump to main content
Jump to site search

Issue 2, 2016
Previous Article Next Article

Naked-eye nanobiosensor for therapeutic drug monitoring of methotrexate

Author affiliations

Abstract

Sensing of methotrexate at clinically-relevant concentrations was achieved with a plasmon-coupling assay. In this assay, free methotrexate and folic acid Au nanoparticles competed for human dihydrofolate reductase (hDHFR)-functionalized Au nanoparticles (Au NP). The hDHFR-functionalized Au NPs were immobilized on a small glass sensor inserted in a portable 4-channel LSPR reader. This allowed rapid (minutes) and sensitive (nanomolar range) measurement of methotrexate concentration by means of total internal reflection plasmonic spectroscopy. The large bathochromic shifts of the plasmon-coupling assay led to striking colour changes visible to the naked eye for methotrexate at clinically-relevant concentrations. The results demonstrate the potential for therapeutic drug monitoring of a widely used chemotherapy agent, as assessed with the naked eye.

Graphical abstract: Naked-eye nanobiosensor for therapeutic drug monitoring of methotrexate

Back to tab navigation

Publication details

The article was received on 17 May 2015, accepted on 28 Jul 2015 and first published on 29 Jul 2015


Article type: Paper
DOI: 10.1039/C5AN00996K
Citation: Analyst, 2016,141, 697-703
  •   Request permissions

    Naked-eye nanobiosensor for therapeutic drug monitoring of methotrexate

    H. Yockell-Lelièvre, N. Bukar, J. L. Toulouse, J. N. Pelletier and J.-F. Masson, Analyst, 2016, 141, 697
    DOI: 10.1039/C5AN00996K

Search articles by author

Spotlight

Advertisements